2018 annual financial data

Corbus Pharmaceuticals Holdings 2018 Net margin

Direct answer

Net margin was -1,154.48%.

Operating income was -56,747,707 USD and net income was -55,672,139 USD.
Operating cash flow was -30,067,255 USD.

Get free Corbus Pharmaceuticals Holdings email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
4,822,272 USD
Operating income
-56,747,707 USD
Net income
-55,672,139 USD
Operating cash flow
-30,067,255 USD